local_hospital

Niepubliczny Zaklad Opieki Zdrowotnej Medem Wilk Sp. j.

Address
lock Available on a paid plan

Gynecology and Women’s Health Research

At Niepubliczny Zaklad Opieki Zdrowotnej Medem Wilk Sp. j. in Katowice, clinical studies in gynecology focus on common and often disruptive conditions affecting women’s health, including endometriosis, bacterial vaginosis, and vulvovaginal candidiasis. These trials are designed to evaluate new treatments, compare care options, and improve symptom control and disease management.

  • Studies on endometriosis and endometriosis-related pain
  • Research in bacterial infections and mycoses affecting the female urogenital system
  • Trials aimed at testing treatment effectiveness and relieving pain or discomfort

The site also contributes to research on reproductive health and symptom relief, helping advance practical options for women with chronic pelvic conditions and infection-related complaints.

Endometriosis and Pelvic Pain Studies

A major part of the research portfolio centers on endometriosis, including studies of endometriosis-related pain and broader disease severity. These trials are evaluating new therapies and treatment approaches intended to reduce pelvic pain, improve daily functioning, and better control a long-term condition that can significantly affect quality of life.

  • Evaluation of new options for endometriosis symptom relief
  • Assessment of treatments for overall pelvic pain and disease severity
  • Research focused on improving outcomes for women living with chronic gynecologic pain

These studies reflect a strong interest in finding more effective ways to manage persistent discomfort and the broader impact of endometriosis in women treated at the site.

Infectious Diseases in Women’s Health

The site is also involved in trials addressing bacterial vaginosis and acute vulvovaginal candidiasis, with additional work in recurrent vulvovaginal candidiasis. This research aims to test whether new or existing treatments can improve clinical cure rates, reduce recurrence, and provide better options for managing vaginal infections.

  • Studies of bacterial vaginosis and treatment effectiveness
  • Trials for acute and recurrent vulvovaginal candidiasis
  • Research focused on infection control, symptom relief, and preventing return of disease

This area of research supports better care for women experiencing frequent or hard-to-treat urogenital infections.

Reproductive Health and Symptom Management

Another important theme is reproductive and urinary physiological phenomena, including studies on prevention of pregnancy and vasomotor symptoms linked to cancer-related endocrine treatment. These trials are designed to assess contraceptive effectiveness and to explore ways of easing treatment-related hot flashes and similar symptoms.

  • Research on contraceptive efficacy and tolerability
  • Studies addressing vasomotor symptoms in women receiving endocrine therapy
  • Trials aimed at improving comfort and supporting everyday wellbeing

By covering both family planning and symptom control, this research adds breadth to the gynecology program at the site and addresses practical needs across different stages of women’s health.

Site Overview

assignment
8
connected trials
corporate_fare
9
sponsors
science
17
IMPs

Activity Indicator

Last 6 months

0
Trials started
-100% vs previous period.
2
Trials started 6–12 months ago
8
Total trials linked
Active
trending_downDeclining-100%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 3 therapeutic areas and 15 of 17 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
2
Sponsors (total)
9
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 1 624 other sites in Poland

description
Trial volume
8
Outperforms 75% of sites
public
Therapeutic diversity
3areas
Outperforms 70% of sites
groups
Sponsor diversity
9sponsors
Outperforms 80% of sites

Therapeutic Area Benchmark — Poland

Select a therapeutic area to compare against other sites in Poland.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Poland

Market Share

Country: Poland

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Niepubliczny Zaklad Opieki Zdrowotnej Medem Wilk Sp. j.

lock Showing 1 of 8 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A multicentre, single arm trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 13 cycles.Chemo Research S.L.Phase IIINot RecruitingJul 2023Aug 2025

IMP list

lock Showing 1 of 17 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Naproxen Sodium2Unknown2024-02-052024-10-21

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.